122 related articles for article (PubMed ID: 16253531)
1. Kinase inhibitor recognition by use of a multivariable QSAR model.
Sprous DG; Zhang J; Zhang L; Wang Z; Tepper MA
J Mol Graph Model; 2006 Jan; 24(4):278-95. PubMed ID: 16253531
[TBL] [Abstract][Full Text] [Related]
2. Fingerprint-based clustering applied to define a QSAR model use radius.
Sprous DG
J Mol Graph Model; 2008 Sep; 27(2):225-32. PubMed ID: 18556228
[TBL] [Abstract][Full Text] [Related]
3. Receptor-based 3D-QSAR studies of checkpoint Wee1 kinase inhibitors.
Wichapong K; Lindner M; Pianwanit S; Kokpol S; Sippl W
Eur J Med Chem; 2009 Apr; 44(4):1383-95. PubMed ID: 18976834
[TBL] [Abstract][Full Text] [Related]
4. Assessing potency of c-Jun N-terminal kinase 3 (JNK3) inhibitors using 2D molecular descriptors and binary QSAR methodology.
Ijjaali I; Petitet F; Dubus E; Barberan O; Michel A
Bioorg Med Chem; 2007 Jun; 15(12):4256-64. PubMed ID: 17451961
[TBL] [Abstract][Full Text] [Related]
5. Kinase-kernel models: accurate in silico screening of 4 million compounds across the entire human kinome.
Martin E; Mukherjee P
J Chem Inf Model; 2012 Jan; 52(1):156-70. PubMed ID: 22133092
[TBL] [Abstract][Full Text] [Related]
6. Novel inhibitors of human histone deacetylase (HDAC) identified by QSAR modeling of known inhibitors, virtual screening, and experimental validation.
Tang H; Wang XS; Huang XP; Roth BL; Butler KV; Kozikowski AP; Jung M; Tropsha A
J Chem Inf Model; 2009 Feb; 49(2):461-76. PubMed ID: 19182860
[TBL] [Abstract][Full Text] [Related]
7. Molecular modeling studies of phenoxypyrimidinyl imidazoles as p38 kinase inhibitors using QSAR and docking.
Ravindra GK; Achaiah G; Sastry GN
Eur J Med Chem; 2008 Apr; 43(4):830-8. PubMed ID: 17706839
[TBL] [Abstract][Full Text] [Related]
8. Combinatorial QSAR modeling of specificity and subtype selectivity of ligands binding to serotonin receptors 5HT1E and 5HT1F.
Wang XS; Tang H; Golbraikh A; Tropsha A
J Chem Inf Model; 2008 May; 48(5):997-1013. PubMed ID: 18470978
[TBL] [Abstract][Full Text] [Related]
9. Application of validated QSAR models of D1 dopaminergic antagonists for database mining.
Oloff S; Mailman RB; Tropsha A
J Med Chem; 2005 Nov; 48(23):7322-32. PubMed ID: 16279792
[TBL] [Abstract][Full Text] [Related]
10. Treating chemical diversity in QSAR analysis: modeling diverse HIV-1 integrase inhibitors using 4D fingerprints.
Iyer M; Hopfinger AJ
J Chem Inf Model; 2007; 47(5):1945-60. PubMed ID: 17661457
[TBL] [Abstract][Full Text] [Related]
11. QSAR study of Akt/protein kinase B (PKB) inhibitors using support vector machine.
Dong X; Jiang C; Hu H; Yan J; Chen J; Hu Y
Eur J Med Chem; 2009 Oct; 44(10):4090-7. PubMed ID: 19497644
[TBL] [Abstract][Full Text] [Related]
12. Three-dimensional quantitative structure-activity relationship studies on novel series of benzotriazine based compounds acting as Src inhibitors using CoMFA and CoMSIA.
Gueto C; Ruiz JL; Torres JE; Méndez J; Vivas-Reyes R
Bioorg Med Chem; 2008 Mar; 16(5):2439-47. PubMed ID: 18065233
[TBL] [Abstract][Full Text] [Related]
13. CoMFA and docking studies on triazolopyridine oxazole derivatives as p38 MAP kinase inhibitors.
Shashi Nayana MR; Sekhar YN; Siva Kumari N; Mahmood SK; Ravikumar M
Eur J Med Chem; 2008 Jun; 43(6):1261-9. PubMed ID: 17825954
[TBL] [Abstract][Full Text] [Related]
14. Structure-based approach to pharmacophore identification, in silico screening, and three-dimensional quantitative structure-activity relationship studies for inhibitors of Trypanosoma cruzi dihydrofolate reductase function.
Schormann N; Senkovich O; Walker K; Wright DL; Anderson AC; Rosowsky A; Ananthan S; Shinkre B; Velu S; Chattopadhyay D
Proteins; 2008 Dec; 73(4):889-901. PubMed ID: 18536013
[TBL] [Abstract][Full Text] [Related]
15. 3D QSAR models built on structure-based alignments of Abl tyrosine kinase inhibitors.
Falchi F; Manetti F; Carraro F; Naldini A; Maga G; Crespan E; Schenone S; Bruno O; Brullo C; Botta M
ChemMedChem; 2009 Jun; 4(6):976-87. PubMed ID: 19326384
[TBL] [Abstract][Full Text] [Related]
16. QSAR modeling of the inhibition of glycogen synthase kinase-3.
Katritzky AR; Pacureanu LM; Dobchev DA; Fara DC; Duchowicz PR; Karelson M
Bioorg Med Chem; 2006 Jul; 14(14):4987-5002. PubMed ID: 16650999
[TBL] [Abstract][Full Text] [Related]
17. Application of Free-Wilson selectivity analysis for combinatorial library design.
Sciabola S; Stanton RV; Johnson TL; Xi H
Methods Mol Biol; 2011; 685():91-109. PubMed ID: 20981520
[TBL] [Abstract][Full Text] [Related]
18. Comparative molecular field analysis and comparative molecular similarity indices analysis of boron-containing human thymidine kinase 1 substrates.
Bandyopadhyaya AK; Tiwari R; Tjarks W
Bioorg Med Chem; 2006 Oct; 14(20):6924-32. PubMed ID: 16828556
[TBL] [Abstract][Full Text] [Related]
19. A comprehensive structure-activity analysis of protein kinase B-alpha (Akt1) inhibitors.
Ajmani S; Agrawal A; Kulkarni SA
J Mol Graph Model; 2010 Apr; 28(7):683-94. PubMed ID: 20153226
[TBL] [Abstract][Full Text] [Related]
20. QSAR modeling of mono- and bis-quaternary ammonium salts that act as antagonists at neuronal nicotinic acetylcholine receptors mediating dopamine release.
Zheng F; Bayram E; Sumithran SP; Ayers JT; Zhan CG; Schmitt JD; Dwoskin LP; Crooks PA
Bioorg Med Chem; 2006 May; 14(9):3017-37. PubMed ID: 16431111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]